{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:31:46Z","timestamp":1787841106021,"version":"build-2784847793"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:00:00Z","timestamp":1744675200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:00:00Z","timestamp":1744675200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Selective elimination of early pathological TAU species may be a promising therapeutic strategy to reduce the accumulation of TAU, which contributes to neurodegeneration and is a hallmark of Alzheimer\u2019s disease (AD). Pathological hyper-phosphorylated TAU can be degraded through selective autophagy, and NDP52\/CALCOCO2 is one of the autophagy receptors involved in this process. In 2021, we discovered a variant of NDP52, called NDP52\n                    <jats:sup>GE<\/jats:sup>\n                    (rs550510), that is more efficient at promoting autophagy. We here anticipate that this variant could be a powerful factor that could eliminate pathological forms of TAU better than its WT form (NDP52\n                    <jats:sup>WT<\/jats:sup>\n                    ). Indeed, we provide evidence that in in vitro systems and in a\n                    <jats:italic>Drosophila melanogaster<\/jats:italic>\n                    model of TAU-induced AD, the NDP52\n                    <jats:sup>GE<\/jats:sup>\n                    variant is much more effective than the NDP52\n                    <jats:sup>WT<\/jats:sup>\n                    in reducing the accumulation of pathological forms of TAU through the autophagic process and rescues typical neurodegenerative phenotypes induced by hTAU toxicity. Mechanistically, we showed that NDP52\n                    <jats:sup>WT<\/jats:sup>\n                    and NDP52\n                    <jats:sup>GE<\/jats:sup>\n                    bind pTAU with comparable efficiency, but that NDP52\n                    <jats:sup>GE<\/jats:sup>\n                    binds the autophagic machinery (LC3C and LC3B) more efficiently than NDP52\n                    <jats:sup>WT<\/jats:sup>\n                    does, which could explain its greater efficiency in removing pTAU. Finally, by performing a genetic analysis of a cohort of 435 AD patients, we defined the NDP52\n                    <jats:sup>GE<\/jats:sup>\n                    variant as a protective factor for AD. Overall, our work highlights the variant NDP52\n                    <jats:sup>GE<\/jats:sup>\n                    as a resilience factor in AD that shows a robust effectiveness in driving pathological TAU degradation.\n                  <\/jats:p>","DOI":"10.1038\/s41419-025-07611-2","type":"journal-article","created":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T08:31:11Z","timestamp":1744705871000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["A variant of the autophagic receptor NDP52 counteracts phospho-TAU accumulation and emerges as a protective factor for Alzheimer\u2019s disease"],"prefix":"10.1038","volume":"16","author":[{"given":"Anna","family":"Mattioni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Carsetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krenare","family":"Bruqi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3503-3318","authenticated-orcid":false,"given":"Valerio","family":"Caputo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3857-9463","authenticated-orcid":false,"given":"Valentina","family":"Cianfanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Giulia","family":"Bacalini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariella","family":"Casa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Gabelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emiliano","family":"Giardina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Cestra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0285-7449","authenticated-orcid":false,"given":"Flavie","family":"Strappazzon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,15]]},"reference":[{"key":"7611_CR1","doi-asserted-by":"crossref","unstructured":"2022 Alzheimer\u2019s disease facts and figures. Alzheimer\u2019s Dement. 2022;18:700\u201389.","DOI":"10.1002\/alz.12638"},{"key":"7611_CR2","doi-asserted-by":"publisher","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","volume":"7","author":"E Nichols","year":"2022","unstructured":"Nichols E, Steinmetz JD, Vollset SE, Fukutaki K, Chalek J, Abd-Allah F, et al. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health. 2022;7:e105\u201325.","journal-title":"Lancet Public Health"},{"key":"7611_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fneur.2023.1178588","volume":"14","author":"RS Madnani","year":"2023","unstructured":"Madnani RS. Alzheimer\u2019s disease: a mini-review for the clinician. Front Neurol. 2023;14:1\u20137.","journal-title":"Front Neurol"},{"key":"7611_CR4","doi-asserted-by":"crossref","unstructured":"Congdon EE, Ji C, Tetlow AM, Jiang Y, Sigurdsson EM. Tau-targeting therapies for Alzheimer's disease: current status and future directions. Nat Rev Neurol. 2023;19:715\u201336.","DOI":"10.1038\/s41582-023-00883-2"},{"key":"7611_CR5","doi-asserted-by":"publisher","first-page":"3895","DOI":"10.3390\/ijms24043895","volume":"24","author":"ACS Vogt","year":"2023","unstructured":"Vogt ACS, Jennings GT, Mohsen MO, Vogel M, Bachmann MF. Alzheimer\u2019s disease: a brief history of immunotherapies targeting amyloid \u03b2. Int J Mol Sci. 2023;24:3895.","journal-title":"Int J Mol Sci"},{"key":"7611_CR6","first-page":"1","volume":"7","author":"C Tissot","year":"2021","unstructured":"Tissot C, Therriault J, Pascoal TA, Chamoun M, Lussier FZ, Savard M, et al. Association between regional tau pathology and neuropsychiatric symptoms in aging and dementia due to Alzheimer\u2019s disease. Alzheimer\u2019s Dement Transl Res Clin Inter. 2021;7:1\u201311.","journal-title":"Alzheimer\u2019s Dement Transl Res Clin Inter"},{"key":"7611_CR7","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1093\/brain\/aww027","volume":"139","author":"R Ossenkoppele","year":"2016","unstructured":"Ossenkoppele R, Schonhaut DR, Sch\u00f6ll M, Lockhart SN, Ayakta N, Baker SL, et al. Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer\u2019s disease. Brain. 2016;139:1551\u201367.","journal-title":"Brain"},{"key":"7611_CR8","doi-asserted-by":"publisher","first-page":"465","DOI":"10.3233\/JAD-160316","volume":"55","author":"J Dronse","year":"2017","unstructured":"Dronse J, Fliessbach K, Bischof GN, Von Reutern B, Faber J, Hammes J, et al. In vivo patterns of tau pathology, amyloid-\u03b2 burden, and neuronal dysfunction in clinical variants of Alzheimer\u2019s disease. J Alzheimer\u2019s Dis. 2017;55:465\u201371.","journal-title":"J Alzheimer\u2019s Dis"},{"key":"7611_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fneur.2013.00072","volume":"4","author":"J G\u00f6tz","year":"2013","unstructured":"G\u00f6tz J, Xia D, Leinenga G, Chew YL, Nicholas HR. What renders TAU toxic. Front Neurol. 2013;4:1\u201310.","journal-title":"Front Neurol"},{"key":"7611_CR10","doi-asserted-by":"publisher","first-page":"223","DOI":"10.2478\/s13380-012-0032-y","volume":"3","author":"KJ Kopeikina","year":"2012","unstructured":"Kopeikina KJ, Hyman BJ, Spires-Jones TL. Soluble forms of tau are toxic in alzheimer\u2019s disease. Transl Neurosci. 2012;3:223\u201333.","journal-title":"Transl Neurosci"},{"key":"7611_CR11","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.2353\/ajpath.2006.050840","volume":"168","author":"TL Spires","year":"2006","unstructured":"Spires TL, Orne JD, SantaCruz K, Pitstick R, Carlson GA, Ashe KH, et al. Region-specific dissociation of neuronal loss and neurofibrillary pathology in a mouse model of tauopathy. Am J Pathol. 2006;168:1598\u2013607. https:\/\/doi.org\/10.2353\/ajpath.2006.050840.","journal-title":"Am J Pathol"},{"key":"7611_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms4496","volume":"5","author":"C Jo","year":"2014","unstructured":"Jo C, Gundemir S, Pritchard S, Jin YN, Rahman I, Johnson GVW. Nrf2 reduces levels of phosphorylated tau protein by inducing autophagy adaptor protein NDP52. Nat Commun. 2014;5:3496.","journal-title":"Nat Commun"},{"key":"7611_CR13","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.tcb.2018.01.003","volume":"28","author":"C Viret","year":"2018","unstructured":"Viret C, Rozi\u00e8res A, Faure M. Novel insights into NDP52 autophagy receptor functioning. Trends Cell Biol. 2018;28:255\u20137. https:\/\/doi.org\/10.1016\/j.tcb.2018.01.003.","journal-title":"Trends Cell Biol"},{"key":"7611_CR14","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.chom.2015.02.008","volume":"17","author":"P Verlhac","year":"2015","unstructured":"Verlhac P, Gr\u00e9goire IP, Azocar O, Petkova DS, Baguet J, Viret C, et al. Autophagy receptor NDP52 regulates pathogen-containing autophagosome maturation. Cell Host Microbe. 2015;17:515\u201325.","journal-title":"Cell Host Microbe"},{"key":"7611_CR15","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.bbrc.2014.10.066","volume":"454","author":"S Kim","year":"2014","unstructured":"Kim S, Lee D, Song JC, Cho SJ, Yun SM, Koh YH, et al. NDP52 associates with phosphorylated tau in brains of an Alzheimer's disease mouse model. Biochem Biophys Res Commun. 2014;454:196\u2013201. https:\/\/doi.org\/10.1016\/j.bbrc.2014.10.066.","journal-title":"Biochem Biophys Res Commun"},{"key":"7611_CR16","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1038\/s41418-021-00766-3","volume":"28","author":"A Di Rita","year":"2021","unstructured":"Di Rita A, Angelini DF, Maiorino T, Caputo V, Cascella R, Kumar M, et al. Characterization of a natural variant of human NDP52 and its functional consequences on mitophagy. Cell Death Differ. 2021;28:2499\u2013516. https:\/\/doi.org\/10.1038\/s41418-021-00766-3.","journal-title":"Cell Death Differ"},{"key":"7611_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0004843","volume":"4","author":"A Bretteville","year":"2009","unstructured":"Bretteville A, Ando K, Ghestem A, Loyens A, B\u00e9gard S, Beauvillain JC, et al. Two-dimensional electrophoresis of tau mutants reveals specific phosphorylation pattern likely linked to early Tau conformational changes. PLoS ONE. 2009;4:1\u20136.","journal-title":"PLoS ONE"},{"key":"7611_CR18","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/j.1365-2818.2006.01706.x","volume":"224","author":"S Bolte","year":"2006","unstructured":"Bolte S, Cordeli\u00e8res FP. A guided tour into subcellular colocalization analysis in light microscopy. J Microsc. 2006;224:213\u201332.","journal-title":"J Microsc"},{"key":"7611_CR19","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider CA, Rasband WS, Eliceiri KW. NIH image to imageJ: 25 years of image analysis. Nat Methods. 2012;9:671\u20135.","journal-title":"Nat Methods"},{"key":"7611_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12859-021-04344-9","volume":"22","author":"DR Stirling","year":"2021","unstructured":"Stirling DR, Swain-Bowden MJ, Lucas AM, Carpenter AE, Cimini BA, Goodman A. CellProfiler 4: improvements in speed, utility and usability. BMC Bioinformatics. 2021;22:1\u201311. https:\/\/doi.org\/10.1186\/s12859-021-04344-9.","journal-title":"BMC Bioinformatics"},{"key":"7611_CR21","first-page":"1","volume":"2015","author":"ST Madabattula","year":"2015","unstructured":"Madabattula ST, Strautman JC, Bysice AM, O\u2019Sullivan JA, Androschuk A, Rosenfelt C, et al. Quantitative analysis of climbing defects in a drosophila model of neurodegenerative disorders. J Vis Exp. 2015;2015:1\u20139.","journal-title":"J Vis Exp"},{"key":"7611_CR22","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"G McKhann","year":"2012","unstructured":"McKhann G. the diagnosis of dementia due to Alzheimer\u2019s disease. Alzheimers Dement. 2012;7:263\u20139.","journal-title":"Alzheimers Dement"},{"key":"7611_CR23","doi-asserted-by":"publisher","first-page":"651971","DOI":"10.3389\/fgene.2021.651971","volume":"12","author":"C Strafella","year":"2021","unstructured":"Strafella C, Caputo V, Termine A, Assogna F, Pellicano C, Pontieri FE, et al. Immune system and neuroinflammation in idiopathic Parkinson\u2019s disease: association analysis of genetic variants and miRNAs interactions. Front Genet. 2021;12:651971.","journal-title":"Front Genet"},{"key":"7611_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1515\/revneuro-2020-0152","volume":"33","author":"M Bell","year":"2022","unstructured":"Bell M, Zempel H. SH-SY5Y-derived neurons: a human neuronal model system for investigating TAU sorting and neuronal subtype-specific TAU vulnerability. Rev Neurosci. 2022;33:1\u201315.","journal-title":"Rev Neurosci"},{"key":"7611_CR25","doi-asserted-by":"crossref","unstructured":"Arendt T, Holzer M, BRUCKNER M, JANKE C, GARTNER U. The use of okadaic acid in vivo and the induction of molecular changes typical for Alzheimer\u2019s disease. Neuroscience. 1998;85:1337\u201340. https:\/\/pubmed.ncbi.nlm.nih.gov\/9681968\/.","DOI":"10.1016\/S0306-4522(97)00697-0"},{"key":"7611_CR26","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.3390\/md11051656","volume":"11","author":"M Medina","year":"2013","unstructured":"Medina M, Avila J, Villanueva N. Use of okadaic acid to identify relevant phosphoepitopes in pathology: a focus on neurodegeneration. Mar Drugs. 2013;11:1656\u201368.","journal-title":"Mar Drugs"},{"key":"7611_CR27","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/S0306-4522(97)00695-7","volume":"85","author":"AK Mudher","year":"1998","unstructured":"Mudher AK, Perry VH. Using okadaic acid as a tool for the in vivo induction of hyperphosphorylated tau. Neuroscience. 1998;85:1329\u201332.","journal-title":"Neuroscience"},{"key":"7611_CR28","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/S0014-5793(98)00346-9","volume":"426","author":"T Tanaka","year":"1998","unstructured":"Tanaka T, Zhong J, Iqbal K, Trenkner E, Grundke-Iqbal I. The regulation of phosphorylation of \u03c4 in SY5Y neuroblastoma cells: The role of protein phosphatases. FEBS Lett. 1998;426:248\u201354. https:\/\/doi.org\/10.1016\/S0014-5793(98)00346-9.","journal-title":"FEBS Lett"},{"key":"7611_CR29","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.tig.2004.06.012","volume":"20","author":"SE McGuire","year":"2004","unstructured":"McGuire SE, Roman G, Davis RL. Gene expression systems in Drosophila: a synthesis of time and space. Trends Genet. 2004;20:384\u201391.","journal-title":"Trends Genet"},{"key":"7611_CR30","first-page":"970980","volume":"2012","author":"M Gistelinck","year":"2012","unstructured":"Gistelinck M, Lambert JC, Callaerts P, Dermaut B, Dourlen P. Drosophila models of tauopathies: what have we learned?. Int J Alzheimers Dis. 2012;2012:970980.","journal-title":"Int J Alzheimers Dis"},{"key":"7611_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnmol.2020.586731","volume":"13","author":"S Jiang","year":"2020","unstructured":"Jiang S, Bhaskar K. Degradation and transmission of tau by autophagic-endolysosomal networks and potential therapeutic targets for tauopathy. Front Mol Neurosci. 2020;13:1\u201319.","journal-title":"Front Mol Neurosci"},{"key":"7611_CR32","doi-asserted-by":"publisher","first-page":"23063","DOI":"10.1074\/jbc.M111.237974","volume":"286","author":"KR Patterson","year":"2011","unstructured":"Patterson KR, Remmers C, Fu Y, Brooker S, Kanaan NM, Vana L, et al. Characterization of prefibrillar tau oligomers in vitro and in Alzheimer disease. J Biol Chem. 2011;286:23063\u201376.","journal-title":"J Biol Chem"},{"key":"7611_CR33","doi-asserted-by":"publisher","first-page":"24374","DOI":"10.1016\/S0021-9258(20)80536-5","volume":"268","author":"E K\u00f6pke","year":"1993","unstructured":"K\u00f6pke E, Tung YC, Shaikh S, Alonso ADC, Iqbal K, Grundke-Iqbal I. Microtubule-associated protein tau: abnormal phosphorylation of a non-paired helical filament pool in Alzheimer disease. J Biol Chem. 1993;268:24374\u201384.","journal-title":"J Biol Chem"},{"key":"7611_CR34","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1111\/j.1460-9568.2008.06084.x","volume":"27","author":"T Hamano","year":"2008","unstructured":"Hamano T, Gendron TF, Causevic E, Yen SH, Lin WL, Isidoro C, et al. Autophagic-lysosomal perturbation enhances tau aggregation in transfectants with induced wild-type tau expression. Eur J Neurosci. 2008;27:1119\u201330.","journal-title":"Eur J Neurosci"},{"key":"7611_CR35","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.1016\/j.jmb.2019.12.028","volume":"432","author":"OJ Lieberman","year":"2020","unstructured":"Lieberman OJ, Sulzer D. The synaptic autophagy cycle. J Mol Biol [Internet]. 2020;432:2589\u2013604. https:\/\/doi.org\/10.1016\/j.jmb.2019.12.028.","journal-title":"J Mol Biol [Internet]"},{"key":"7611_CR36","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.3233\/JAD-200716","volume":"78","author":"A Singh","year":"2020","unstructured":"Singh A, Allen D, Fracassi A, Tumurbaatar B, Natarajan C, Scaduto P, et al. Functional Integrity of synapses in the central nervous system of cognitively intact individuals with high alzheimer\u2019s disease neuropathology is associated with absence of synaptic tau oligomers. J Alzheimer\u2019s Dis. 2020;78:1661\u201378.","journal-title":"J Alzheimer\u2019s Dis"},{"key":"7611_CR37","doi-asserted-by":"publisher","first-page":"5355","DOI":"10.1002\/alz.13074","volume":"19","author":"B Tumurbaatar","year":"2023","unstructured":"Tumurbaatar B, Fracassi A, Scaduto P, Guptarak J, Woltjer R, Jupiter D, et al. Preserved autophagy in cognitively intact non-demented individuals with Alzheimer\u2019s neuropathology. Alzheimer\u2019s Dement. 2023;19:5355\u201370.","journal-title":"Alzheimer\u2019s Dement"},{"key":"7611_CR38","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.molcel.2012.08.024","volume":"48","author":"N von Muhlinen","year":"2012","unstructured":"von Muhlinen N, Akutsu M, Ravenhill BJ, Foeglein \u00c1, Bloor S, Rutherford TJ, et al. LC3C, Bound selectively by a noncanonical LIR motif in NDP52, is required for antibacterial autophagy. Mol Cell. 2012;48:329\u201342.","journal-title":"Mol Cell"},{"key":"7611_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cells9092008","volume":"9","author":"N Wesch","year":"2020","unstructured":"Wesch N, Kirkin V, Rogov VV. Atg8-family proteins-structural features and molecular interactions in autophagy and beyond. Cells. 2020;9:1\u201325.","journal-title":"Cells"},{"key":"7611_CR40","doi-asserted-by":"publisher","first-page":"e111372","DOI":"10.15252\/embj.2022111372","volume":"42","author":"T Kataura","year":"2023","unstructured":"Kataura T, Otten EG, Rabanal-Ruiz Y, Adriaenssens E, Urselli F, Scialo F, et al. NDP52 acts as a redox sensor in PINK1\/Parkin-mediated mitophagy. EMBO J. 2023;42:e111372.","journal-title":"EMBO J"},{"key":"7611_CR41","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1074\/jbc.M117.809293","volume":"293","author":"B Falcon","year":"2018","unstructured":"Falcon B, Noad J, McMahon H, Randow F, Goedert M. Galectin-8-mediated selective autophagy protects against seeded tau aggregation. J Biol Chem. 2018;293:2438\u201351. https:\/\/doi.org\/10.1074\/jbc.M117.809293.","journal-title":"J Biol Chem"},{"key":"7611_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38572-9","volume":"14","author":"\u00c1 dos Santos","year":"2023","unstructured":"dos Santos \u00c1, Rollins DE, Hari-Gupta Y, McArthur H, Du M, Ru SYZ, et al. Autophagy receptor NDP52 alters DNA conformation to modulate RNA polymerase II transcription. Nat Commun. 2023;14:2855.","journal-title":"Nat Commun"},{"key":"7611_CR43","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1002\/glia.24160","volume":"70","author":"IC Stancu","year":"2022","unstructured":"Stancu IC, Lodder C, Botella Lucena P, Vanherle S, Guti\u00e9rrez de Rav\u00e9 M, Terwel D, et al. The NLRP3 inflammasome modulates tau pathology and neurodegeneration in a tauopathy model. Glia. 2022;70:1117\u201332.","journal-title":"Glia"},{"key":"7611_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40478-020-00896-8","volume":"8","author":"J Zheng","year":"2020","unstructured":"Zheng J, Akbari M, Schirmer C, Reynaert ML, Loyens A, Lefebvre B, et al. Hippocampal tau oligomerization early in tau pathology coincides with a transient alteration of mitochondrial homeostasis and DNA repair in a mouse model of tauopathy. Acta Neuropathol Commun. 2020;8:1\u201323.","journal-title":"Acta Neuropathol Commun"},{"key":"7611_CR45","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/alz.12683","volume":"19","author":"T Ashleigh","year":"2023","unstructured":"Ashleigh T, Swerdlow RH, Beal MF. The role of mitochondrial dysfunction in Alzheimer\u2019s disease pathogenesis. Alzheimer\u2019s Dement. 2023;19:333\u201342.","journal-title":"Alzheimer\u2019s Dement"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07611-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07611-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07611-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T08:31:14Z","timestamp":1744705874000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07611-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,15]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7611"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-07611-2","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,15]]},"assertion":[{"value":"31 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The patients from IRCCS Santa Lucia Foundation Hospital of Rome were enrolled for a previous study approved by the Ethical Committee (CE\/PROG.650 approved on 01\/03\/2018). The patients from the memory clinic of CRIC in Padua were collected according to the study protocol \u201cAnalisi delle Basi Biologiche della Malattia di Alzheimer eredofamiliare e delle forme sporadiche tardive\u201d (3950\/AO\/2016) approved by the local ethic committee of the recruitment center on October 06th, 2016. All peripheral blood samples were collected after obtaining the written informed consent of the study participants, in accordance with the Helsinki Declaration.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"300"}}